Open AccessAmiodarone-induced thyrotoxicosis refractory to medical therapy: A case report
Author(s) -
Francisco Javier Gómez,
Paloma Gónzalez,
Rocío Juárez,
Virgilio Martínez,
Manuel José Suárez Fernández,
Cristina Contreras,
Álvaro GarcíaManzanares
Publication year - 2019
Publication title -
medicina clínica práctica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.101
H-Index - 1
ISSN - 2603-9249
DOI - 10.1016/j.mcpsp.2019.04.002
Subject(s) - amiodarone , medicine , refractory (planetary science) , triiodothyronine , thyroid function , thyroid , atrial fibrillation , physics , astrobiology
Amiodarone is a potent class III antiarrhythmic drug used for both supra and ventricular tachyarrhythmias. Due to its high iodine content and similar structure to thyroxine (T4) and triiodothyronine (T3), abnormalities in thyroid function are common (hyper/hypothyroidism) in patients taking amiodarone, especially with long term use. We present the case of a patient with amiodarone-induced thyrotoxicosis (AIT), refractory to medical therapy, which required total thyroidectomy for symptomatic control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom